Kirkland & Ellis represented the placing agents in the deal.Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (“Kelun-Biotech”) announced it completed the H-share placing (the “H-Share Placing”). Kelun-Biotech has…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
